Sign in

Christina Metoikidou

@christinamt.bsky.social
81 followers 80 following 6 posts

Postdoctoral Researcher at The Netherlands Cancer Institute | PhD at Institut Curie 👩🏻‍🔬 | 👩🏻‍💻 #cancerimmunology

PostsRepliesMedia
Reposted by Christina Metoikidou
EACR - European Association for Cancer Research @helloeacr.bsky.social · 01/09/2026
"This fellowship has provided crucial support for the development of my research programme." Christina Metoikidou is a 2025 recipient of an EACR- @themarkfdn.bsky.social Postdoctoral Fellowship - read more here: magazine.eacr.org/christina-me...
042
Christina Metoikidou @christinamt.bsky.social · 09/06/2026
It was a pleasure to present my research at #EACR2026, supported by @helloeacr.bsky.social @themarkfdn.bsky.social postdoctoral fellowship. Thank you to all organizers & participants!
0102
Christina Metoikidou @christinamt.bsky.social · 23/12/2025
Right before the holidays, happy to share our new preprint 🌲 The 3rd main part of my PhD, from a simple idea long before the spatial era boom: how do tissues from different regions of the same tumor differ in immune cell states and TCR clonality? Thanks to all co-authors for their work and support!
020
Reposted by Christina Metoikidou
Nature Metabolism @natmetabolism.nature.com · 09/12/2025
bit.ly
Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses
Nature Metabolism, Published online: 09 December 2025; doi:10.1038/s42255-025-01415-6Dietary restriction promotes the expansion of effector T cells via ketone bodies, which enhances anti-tumour immunity and synergizes with immunotherapy in mice.
084
Reposted by Christina Metoikidou
Trends in Immunology @cp-trendsimmuno.bsky.social · 17/06/2025
The T cell subsetting challenge #immunology
dlvr.it
The T cell subsetting challenge
Exploiting specific T cell subset properties bears potential for T cell therapies but is complicated by inconsistencies in T cell subset definitions and markers. Here, we discuss causes for the definition and classification complexities to provide a handle for how to navigate the T cell subset jungle.
081
Christina Metoikidou @christinamt.bsky.social · 16/06/2025
So happy to be back in beautiful Lisbon for #EACR2025! Looking forward to the fantastic scientific talks ahead, and to discussing our study on the spatial organization of intratumour immune heterogeneity (poster P-755 tomorrow!)🪻
050
Reposted by Christina Metoikidou
Institut Curie @institutcurie.bsky.social · 06/06/2025
📍 8th Course on Computational Systems Biology of Cancer “Multimodal data analysis and network modelling to master cancer hallmarks” at Institut Curie. ➡️ Registration open until June 15: training.institut-curie.org/courses/csbc...
084
Reposted by Christina Metoikidou
The Mark Foundation for Cancer Research @themarkfdn.bsky.social · 19/03/2025
We are thrilled to support these outstanding scholars! Congratulations, @juliemmazet.bsky.social, @christinamt.bsky.social, and @marthamz.bsky.social! 🎉
072
Christina Metoikidou @christinamt.bsky.social · 19/03/2025
Happy to share that I have been awarded the EACR-Mark Foundation Postdoctoral Fellowship! This funding supports my project on identifying TME signals shaping distinct CD8 T cell states at @danielathommen.bsky.social @nkinl.bsky.social. Grateful for this opportunity! Congrats to all the recipients!
131
Christina Metoikidou @christinamt.bsky.social · 10/03/2025
Excited to share my first post & see the second part of my PhD work published! Our study on mTNBC highlights that baseline clonal expansion of dysfunctional CD8 cells is linked to better response to chemoimmunotherapy. More here: www.sciencedirect.com/science/arti... #CD8 #TCellExhaustion #TNBC
sciencedirect.com
Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer
Chemotherapy combined with immune checkpoint blockade has shown clinical activity in breast cancer. Response, however, occurs in only a low proportion…
151